Deals activity: YoY decline in South and Central America; private equity deals are up
Deals activity by geography
Medical industry deals, as captured by GlobalData’s Medical Intelligence Centre, are up year-on-year (YoY) across all regions.
North America is leading in terms of deal value, but recorded the second lowest YoY growth in deals volume at 10%. Asia-Pacific, ranking third in terms of deal value, has seen the biggest YoY change, with deal volumes increasing by 76%.
The volume of deals recorded by GlobalData also increased YoY in Europe (33%) and Middle East and Africa (46%), but declined in South and Central America (-5%)
Deals activity by type
|Deal type||Total deal value (US$m)||Total deal count||YoY change (volume)|
A breakdown of deals by type and volume shows a 21980% growth in mergers YoY, while acquisitions are down 65%, partnerships are up 29% and asset transactions are down 13%. Financing deals have increased across some types, with venture financing up 52% YoY, equity offerings up 140% and debt offerings up 8%.
Private equity has grown by 73% in number of deals YoY, while the number of grants recorded is up 24%.
Deals activity by therapy area
The most notable development apparent in GlobalData’s analysis of medical industry deals by therapy area is the increase of deals in the field of in vitro diagnostics. After remaining relatively steady over the past ten years, the number of recorded deals in vitro diagnostics increased significantly in 2020. This is likely due to demand caused by the ongoing Covid-19 pandemic.
Note: All numbers as of 03 December 2020. Deals captured by GlobalData cover M&As, strategic alliances, various types of financing and contract service agreements.
For more insight and data, visit GlobalData's Medical Intelligence Centre
Latest deals in brief
Zimmer Biomet acquires sternal closure device company A&E Medical
Zimmer Biomet has acquired Vance Street Capital portfolio company A&E Medical, which manufactures sternal closure devices, for a total of $250m. According to the agreement, A&E Medical will receive $150m in cash at closing of the deal and $100m in cash payable next year from Zimmer Biomet.
Aspen Surgical acquires Protek Medical Products
Surgical disposable products maker Aspen Surgical Products has acquired Iowa-based Protek Medical Products for an undisclosed amount. Protek makes single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration and vascular access procedures. It also manufactures protective covers for medical instruments and equipment.
GE Healthcare to acquire Swedish start-up Prismatic Sensors
GE Healthcare is set to acquire Swedish start-up Prismatic Sensors in an effort to expand its portfolio in photon-counting CT technology. This technology can potentially set a base for a new standard of care in oncology, cardiology, neurology and many other clinical CT applications. These include visualisation of minute details of organ structures, improved tissue characterisation, more accurate material density measurement and lower radiation dose.
Qiagen and BioNTech to develop test for head and neck cancer
Qiagen and BioNTech have announced a strategic collaboration to develop and commercialise a tissue-based therascreen test to identify patients with squamous cell carcinoma of the head and neck. They are caused by specific infections by human papillomavirus. The test will be used along with BioNTech’s investigational cancer treatment, BNT113.
Cipla signs licensing agreement with Multi G for Covid-19 test kit
Indian pharma company Cipla has signed a licensing agreement with Multi G in Belgium for the distribution of its Covid-19 rapid antibody test kit, Covi-G, in Europe and other emerging markets. According to the deal, Cipla will handle the distribution of Covi-G that will be manufactured by MultiG. The company’s latest agreement is aimed at increasing global access to life-saving therapies and diagnostic infrastructure for people in need.
Medtronic acquires French spinal implant maker Medicrea
Medtronic has completed its friendly tender offer to acquire France-based artificial intelligence-enabled spinal implant manufacturer Medicrea International. In July, the companies signed an agreement for the acquisition of all outstanding shares of Medicrea in a voluntary all-cash tender offer priced at €7 ($7.97) per share. With the completion of the tender offer, Medtronic now owns over 90% of Medicrea’s share capital and voting rights.